StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca seloken / Toprol-XL (metoprolol) — Emerging Markets product sales ($M) ($M)

Form 6-K / 20-F Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
153
Period ended Jun 30, 2026
Change on a year earlier
+7.0%
143 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSeloken / Toprol-XL (metoprolol) — Emerging Markets product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026153+7.0%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026174+12.3%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025134-2.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025153+5.5%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025143-2.1%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025155-3.7%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024137-1.4%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024145-2.7%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024146-8.2%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024161-6.9%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023139-7.3%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023149-36.1%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023159-27.1%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023173-27.3%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022150-23.9%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022233+2.6%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up seloken / toprol-xl (metoprolol) — emerging markets product sales ($m)

Cite this data

StockData. (2026). AstraZeneca Seloken / Toprol-XL (metoprolol) — Emerging Markets product sales ($M) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_seloken_em

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.